This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit Sep. 10, 2012

Home   The Society   Meetings   Advocacy   Contact Us


7 scientists win prestigious Lasker medical awards; liver transplant developers among winners
The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Seven scientists have won prestigious medical awards for development of liver transplantation, discoveries about the inner workings of cells and leadership in biomedical science. The prizes, worth $250,000 for each of three categories, will be presented in New York on Sept. 21. More


ASTS Recognition Awards deadline extended to Sept. 21
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The deadline to submit nominations for the ASTS Recognition Awards has been extended to Friday, Sept. 21. You may nominate yourself or someone else for the Vanguard Prize or Advanced Transplant Provider Award. If you are a junior member of ASTS (either a candidate member or junior faculty within seven years of your fellowship), you may nominate your mentor for the 2013 Francis Moore Excellence in Mentorship in the Field of Transplantation Surgery Award by writing a short description of your mentor's contributions to their training and career and providing his or her CV. More

ACOT meeting presentations available
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Advisory Committee on Organ Transplantation met the last week of August, and several ASTS members were among the presenters, including ASTS President Kim M. Olthoff, MD, in her role as chair of the OPTN Liver Committee. The presentations covered a wide range of topics including: liver allocation policy update; an update from the Achieving Consensus on Increased Risk Donors to Improve Access to Organ Transplantation Meeting; informed consent for vascularized composite allografts; and kidney paired donation challenges. More

ASTS Transplant Center Policy Library — subscribe today!
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Are you looking for a centralized place to access standard business operating procedures you need in running your transplant center? The ASTS Business Practice Services Committee has developed a dynamic subscription service of sample policies and templates to provide transplant centers with the building blocks they need to successfully manage and navigate the growing regulatory and quality improvement environment. The ASTS Transplant Center Policy Library is available as an annual subscription in the ASTS Store. More


New approaches for optimizing transplant of sensitized patients
Current Opinion in Organ Transplantation    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Sensitization to human leukocyte antigens (HLA) remains a major barrier to transplantation for those patients who have developed anti-HLA antibodies subsequent to exposure to HLA through pregnancy, blood transfusions, and prior transplant. More

Adjuvanted influenza vaccine safe in kidney transplant recipients
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The use of adjuvanted pandemic 2009 influenza vaccine appears to be safe in terms of risk for acute rejection and long-term graft outcome in kidney transplant recipients, researchers reported at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. "Some transplant groups have recently raised concerns about the safety of adjuvanted influenza vaccination in terms of graft survival," said lead investigator Mario Fernandez-Ruiz, M.D. More

Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The significance of donor-specific antibodies is not well known in the setting of pancreas transplantation. Since December 2009, researchers prospectively followed pancreas transplant patients with single-antigen-luminex-bead testing at one, two, three, six and then every six months for the first two years. More

Latinos high on organ transplant waiting list but many fear becoming donors
The Oregonian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Carlos Aguilar, 20, sees a doctor so often that he calls the medical clinic he regularly frequents his second home. Aguilar, who has kidney disease, has been at the clinic for about 10 hours every week for the last two years. There, his slight frame is hooked up to a dialysis machine that filters toxins out of his blood and removes excess liquid – a job his kidneys would do if they worked at more than 5 percent of the normal rate. More

Chronic renal outcome after living donor liver transplantation
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Chronic kidney disease is one of the common complications after deceased donor liver transplantation. Although the worldwide pressing shortage in deceased donors has directed attention to living donor liver transplantation, LDLT cohort data focusing on chronic renal dysfunction is limited. A total of 280 adult LDLT recipients (median 49 yr, 156 men) at the University of Tokyo hospital between 1996 and 2006 were reviewed. More

Surgeons perform world's first simultaneous kidney transplant and weight loss surgery
Medical Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A 35-year-old woman from Chicago named Aidee Diaz has become the world's first woman to simultaneously undergo a kidney transplant and sleeve gastrectomy. After being diagnosed with kidney disease, Diaz was put on steroids and other medications and, due to these medications, her weight increased from 180 pounds to 300 pounds. She required dialysis three times a week. More

Guidry & East

Guidry & East is a transplant consulting firm specializing in Transplant business solutions, Transplant financial and operations, along with the Medicare Organ Acquisition Cost Report.
Advertise here!

To find out how to feature your company in the ASTS Newsbrief and other advertising opportunities, Contact James DeBois at 469-420-2618

Clinical factors predicting readmission after orthotopic liver transplantation
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hospitals with the highest readmission rates for high-cost conditions may be targeted for payment penalties. The primary aim of this study was to determine clinical predictors of 30-day readmission after discharge for patients undergoing orthotopic liver transplantation at the University of Washington from January 2003 to October 2010. More

Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In living donor liver transplantation (LDLT), a right liver graft is larger than a left liver graft and hence leads to better recipient survival. However, in comparison with donor left hepatectomy, donor right hepatectomy carries a higher donor risk. We estimated the expansion of the applicability of left liver living donor liver transplantation (LLDLT) by lowering the graft weight (GW)/standard liver volume (SLV) ratio in increments of 5 percent. More

Optimal treatment for most common infection after organ transplantation
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Waiting to treat the most common viral infections in transplant recipients until they reach a certain threshold is better than prophylactically treating all recipients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. Cytomegalovirus infection is the most common infection in organ transplant recipients, who are susceptible to infections in general because they must take immunosuppressive medications long term. More

Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
By analyzing 26,414 patients [12,589 with hepatitis C virus (HCV)] in the Scientific Registry of Transplant Recipients database, researchers sought to determine comparative risk factors (including primary immunosuppression) predictive of death and graft loss among patients with HCV and patients without HCV. This study suggests a novel association between sirolimus use and an increased risk of death and graft loss after liver transplantation in HCV patients that is not seen in patients without HCV. More

Kidney transplant recipient designs software that saves lives
J. the Jewish news weekly of Northern California    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A kidney transplant that saved him from the disease that killed his father and brother inspired David S. Jacobs to use his technology skills to save the lives of other people awaiting transplants. Jacobs, a sales, marketing and business development executive in the technology industry, has spent the past seven years developing a software program that matches people needing kidneys with donors. More

ASTS NewsBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Tammy Gibson, Content Editor, 469.420.2677   
Contribute news

This edition of the ASTS NewsBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 10, 2012
Aug. 27, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063